New database aims to unlock secrets of breast cancer survivors
NCT ID NCT04999826
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study collected information and samples from 105 breast cancer survivors and healthy volunteers to create a research database. The goal is to help doctors better diagnose cancer, predict long-term health, and develop future treatments. Participants provided blood, urine, and stool samples and answered questionnaires about their quality of life.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this database could help researchers better understand breast cancer survivors' health and guide future treatments.
- What could go wrong
- This is an observational study that only collects data, so it won't directly improve health. It may not lead to any new treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
105 people
The number who actually took part.
- Started
-
Apr 2021
- Finished
-
Dec 2022
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients diagnosed with breast cancer stages 0 through 3 at time of diagnosis
- Ages
-
18 to 75 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * BCS GROUP * Female patients diagnosed with breast cancer age 18 - 75, stages 0 through 3 at time of diagnosis * Who have completed active therapy (including surgery, radiation, and/or chemotherapy) * Able to speak English and complete surveys and provide the specimen (willing to follow the sample collection instructions) * Able to read, understand and sign inform consent * CONTROL GROUP * Healthy Volunteers age 18 - 75 * Able to speak and read English, complete consent, surveys, and provide specimens Exclusion Criteria: * Unable to give written consent * Unable to fast before providing blood and urine * Pregnant women (per participant report) and males * Unwilling to travel to Mayo Clinic Rochester to provide bio specimens
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Anatomic stage 0 breast cancer ajcc V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- 3D imaging could help surgeons remove all breast cancer in one go
- Can a Weight-Loss drug shield breast cancer Survivors' hearts?
- Fasting during chemo: a new way to boost treatment?
- Gut bacteria may fortify bones in breast cancer therapy
- Digital therapy aims to tame the fear that haunts cancer survivors
- A remote diet and exercise program aims to help rural cancer survivors shed pounds and lower recurrence risk